跳至主要内容
临床试验/ISRCTN53193024
ISRCTN53193024已完成未知

A study to determine the maintenance of efficacy of agomelatine (25 mg to 50 mg) to prevent relapse in out-patients with Major Depressive Disorder. A 8 to 10 weeks open period treatment with agomelatine (25 mg to 50 mg) followed by 24 weeks randomised double-blind period, placebo-controlled, parallel groups and 20 weeks of optional double-blind treatment period.

Institut de Recherches Internationales Servier (France)0 个研究点目标入组 500 人开始时间: 2007年3月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
500

研究概览

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged 18 to 65 years
  • 2. Male or female
  • 3. Out-patients
  • 4. Requiring an antidepressant treatment

排除标准

  • 1. All types of depression other than major depressive disorder
  • 2. Severe or uncontrolled organic disease
  • 3. Pregnant or breastfeeding women

研究者

发起方
Institut de Recherches Internationales Servier (France)

相似试验